万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>化学>>生化与分子生物学
您的位置:万维书刊网 >>sci/e期刊大全 >>化学>>化学综合
您的位置:万维书刊网 >>sci/e期刊大全 >>化学>>有机化学
您的位置:万维书刊网 >>sci/e期刊大全 >>生物科学>>生化研究方法

BIOCONJUGATE CHEMISTRY《生物共轭化学》 (官网投稿)

简介
  • 期刊简称BIOCONJUGATE CHEM
  • 参考译名《生物共轭化学》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率5.40%
  • 主要研究方向化学-BIOCHEMICAL RESEARCH METHODS 生化研究方法;CHEMISTRY, MULTIDISCIPLINARY 化学综合;CHEMISTRY, ORGANIC 有机化学;BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学

主要研究方向:

等待设置主要研究方向
化学-BIOCHEMICAL RESEARCH METHODS 生化研究方法;CHEMISTRY, MULTIDISCIPLINARY 化学综合;CHEMISTRY, ORGANIC 有机化学;BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学

BIOCONJUGATE CHEMISTRY《生物共轭化学》(月刊). Bioconjugate Chemistry invites original contributions on all research at the interface between man-made and&n...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://pubs.acs.org/journal/bcches

3、投稿网址:https://acs.manuscriptcentral.com/acs

4、官网邮箱:rotello@chem.umass.edu(主编)

更多编辑邮箱如下。

5、官网电话:(413) 545-2058(主编)

6、期刊刊期:月刊,一年出版十二期。

2021414日星期三

                              

 

编辑邮箱【官网信息】

 

Editors & Editorial Board

Editor-in-Chief

Vincent Rotello

University of Massachusetts Amherst

United States

E-mail: eic@bioconj.acs.org

 

Associate Editors

Zhifei Dai

Peking University

China

E-mail: dai-office@bioconj.acs.org

Erin Lavik

University of Maryland, Baltimore County

United States

E-mail: lavik-office@bioconj.acs.org

Bradley Smith

University of Notre Dame

United States

E-mail: smith-office@bioconj.acs.org

Jan C. M. van Hest

TU/e Eindhoven University of Technology

Netherlands

E-mail: vanhest-office@bioconj.acs.org

Gang Zheng

University of Toronto, Univ. Health Network

Canada

E-mail: zheng-office@bioconj.acs.org

 

投稿须知【官网信息】

 

Information for Authors

Author Guidelines

Scope Of The Journal

Bioconjugate Chemistry invites original contributions on all research at the interface between man- made and biological materials. The mission of the journal is to communicate advances in a wide range of fields including drug delivery, bionanotechnology, and synthetic biology. Bioconjugate Chemistry is intended to provide a forum for presentation of rigorous research relevant to all aspects of bioconjugates, including the preparation, properties, and applications of molecular conjugates.

For more information, please visit “About the Journal”.

Manuscript Types

Bioconjugate Chemistry publishes original Communications, Articles, and Reviews. The editors welcome the submission of manuscripts in the following categories:

Communications. Pioneering reports of with impact and general interest to justify accelerated publication. Communications should be brief, 2000-3000 words or the equivalent, without key data relegated to the supporting information.

Articles. Comprehensive accounts of significant studies should be submitted as Articles. The majority of publications are in this category, where very often the research story can be told more effectively.

Articles are normally 3500-5000 words and up to 7 figures.

Reviews. There are two types of Reviews: Reviews and Topical Reviews. Topical Reviews are intended to introduce the readership to new topics and challenges through the personal viewpoint of the authors.

These articles can describe new strategies in bioconjugation, or describe the role of synthetic/biological constructs in topics such as immunology, cancer therapeutics, and tissue engineering. Topical Reviews provide concise (2000-3000 word) overviews of both fundamental topics and translational issues, with a target audience of advanced graduate students, post-docs, and faculty looking to extend their research in new directions. Reviews provide a forum for more in-depth coverage of an area, and likewise should be accessible to the broad audience of Bioconjugate Chemistry. These reviews will typically be 4000- 6000 words in length. The use of effective figures is strongly encouraged for both Topical Reviews and Reviews.

Comments. Comments are commissioned by the editors and are generally short and concise assessments of the literature (1000-2000 words).

Our goal at Bioconjugate Chemistry is to make the submission and review process as quick and painless as possible. More details are available in the following sections.

ACS Publishing Center

While this document will provide basic information on how to prepare and submit the manuscript as well as other critical information about publishing, we also encourage authors to visit the ACS Publishing Center for additional information on everything that is needed to prepare (and review) manuscripts for ACS journals and partner journals, such as

Mastering the Art of Scientific Publication, which shares editor tips about a variety of topics including making your paper scientifically effective, preparing excellent graphics, and writing cover letters.

Resources on how to prepare and submit a manuscript to ACS Paragon Plus, ACS Publications’ manuscript submission and peer review environment, including details on selecting the applicable Journal Publishing Agreement.

Sharing your research with the public through the ACS Publications open access program.

ACS Reviewer Lab, a free online course covering best practices for peer review and related ethical considerations.

Manuscript Preparation

Review Ready Submission

All ACS journals and partner journals have simplified their formatting requirements in favor of a streamlined and standardized review-ready format for an initial manuscript submission. Read more about the requirements and the benefits these serves authors and reviewers here.

Manuscripts submitted for initial consideration must adhere to these standards:

Submissions must be complete with clearly identified standard sections used to report original research, free of annotations or highlights, and include all numbered and labeled components.

Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance. Separate graphics can be supplied later at revision, if necessary.

A two-column manuscript template is available and can be used for manuscripts submitted to any ACS journal or partner journal. Templates are not required but may be useful to approximate how an article will compose. For manuscripts with word count limits, authors are not required to fit content into a page limit based on the template.

References can be provided in any style, but they must be complete, including titles.

Supporting Information should be submitted as a separate file(s).

Author names and affiliations on the manuscript must match what is entered into ACS.

Document Templates and Format

General information on the preparation of manuscripts may be found in the ACS Guide to Scholarly Communication.

Acceptable Software, File Designations, and TeX/LaTeX

See the list of Acceptable Software and appropriate File Designations to be sure your file types are compatible with ACS Paragon Plus. Information for manuscripts generated from TeX/LaTeX is also available.

Cover Letter

A cover letter must accompany every manuscript submission. During the submission process, you may type it or paste it into the submission system, or you may attach it as a file.

We strongly encourage that the cover letter specifically state the innovation of the submitted manuscript. It should provide the postal address, telephone number, fax number, and e-mail address of the corresponding author of the manuscript. All editorial correspondence concerning receipt, status, review, revision, and publication of a manuscript will be directed to the corresponding author, who is responsible for communicating the manuscript status to all coauthors of the paper and for obtaining the coauthors’ assent to any substantial changes of content or interpretation made during revision.

Manuscript Text Components

Articles should be assembled in the order Title (including full title, byline, and associated footnotes), Abstract, Introduction, Results and Discussion, Experimental Procedures (Materials and Methods), Acknowledgments, Supporting Information description, Abbreviations, References, and Footnotes, and a Table of Contents graphic (TOC). For Communications, the need for brevity precludes subdivisions within the text for introduction, experimental procedures, results, and discussion; experimental procedures should be placed in Supporting Information, incorporated into the text or figure captions, or included as footnotes in Communications. Authors must also submit a small structural diagram or other informative illustration that represents or summarizes the topic for use in the Table of Contents (TOC) and abstract.

Title Page. A brief, accurate, and informative title will aid in the classification and indexing of the paper. Do not use trade names of drugs or abbreviations. List full names and institutional affiliations of all authors, and if differentiation is necessary, indicate the affiliations of the authors by the superscript symbols †, ‡, §, etc. The author to whom correspondence should be addressed is indicated by an asterisk. The corresponding author’s address should include a street address, or post office box number if no street address is available, and an e-mail address. The corresponding author’s current telephone and fax numbers should also be included. It is implicit in listing a person as an author that this individual has agreed to appear as an author of the manuscript.

Abstract. The abstract should briefly present the problem and experimental approach and state the major findings and conclusions. It should be self-explanatory and suitable for reproduction without rewriting. Footnotes or undefined abbreviations may not be used in the abstract. The abstract will be formatted as one paragraph without any subheads or other divisions.

Keywords. Authors should provide a list of up to six keywords to be displayed below the abstract of their publication.

Introduction. The introduction should state the purpose of the investigation and its relation to other work in the field. Background material should be brief and relevant to the research described. Lengthy reviews of the literature should be avoided.

Results and Discussion. Normal formatting of the manuscript will have a combined Results and Discussion section, however authors may provide these as separate sections. The results should be presented concisely. In the interest of economy of space in the article, it is often desirable to place supplementary data (also subject to review) in a separate document for publication as Supporting Information on the Web. Recent issues of the journal should be consulted for current practices.

Tables and figures should be designed to make it easy for the reader to understand the experimental data. The same data should not be presented in more than one figure or in both a figure and a table in the manuscript. In some cases it is appropriate to validate the significance of processed data (e.g., a graph), by including the underlying raw data (e.g., a gel or biodistribution) as Supporting Information.

Experimental Procedures. The experimental procedures should be described in sufficient detail to enable others to repeat the experiments. Names of products and manufacturers should be included only if they are not widely known or if alternate sources are deemed unsatisfactory. Novel experimental procedures should be described in detail.

Care should be taken to describe any differences between published methods and methods actually used. Published procedures should be referred to by literature citation of both the original and any published modifications, unless the information is so fragmented that the reader would benefit from a unified presentation.

Acknowledgment. This section should acknowledge financial support, technical assistance, advice from colleagues, gifts, etc. Sources of funding of the research should be stated. Permission should be sought from persons whose contribution to the work is acknowledged in the manuscript.

References. All the references and footnotes must be placed together in a list at the end of the manuscript text. In the Web edition, many of them will have links to other Web resources, such as the corresponding abstracts in Chemical Abstracts and the full text on publisher Web sites. Because of this electronic linking, and to aid scientific research, it is crucial that authors verify the accuracy of all reference citations and footnotes.

Unnecessarily long lists of references should be avoided, and excessive self-citation is strongly discouraged. However, authors must reference all previous publications in which portions of the present work have appeared. Literature references and explanatory footnotes must be numbered with Arabic numerals in the order of their first citation in the text and the corresponding numbers placed at the appropriate locations in the text as superscripted numerals without parentheses or bracket. The title of the article must be included in the reference, as shown in the following examples:

For periodicals, follow the format shown: Fritzberg, A. R., Abrams, P. G., Beaumier, P. L., Kasina, S., Morgan, A. C., Reno, J. M., Sanderson, J. A., Srinivasan, A., Wilbur, D. S., and Vanderheyden, J. (1988) Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. U.S.A. 85, 4025–4029.

Inclusive pagination is preferred. Titles of journals are abbreviated according to Chemical Abstracts Service Source Index. Serial publications such as Methods in Enzymology and C.R.C. Critical Reviews should be listed in the same form as journals. For journal articles accessed online prior to print publication, please provide the DOI number.

For books, follow the format shown: Aida, T., and Jiang, D.-L. (2000) Dendrimer porphyrins and metalloporphyrins: syntheses, structures and functions. The Porphyrin Handbook. Volume 3: Inorganic, Organometallic and Coordination (Kadish, K. M., Smith, K. M., and Guilard, R., Eds.) pp 369–384, Chapter 23, Academic Press, New York.

Submitted manuscripts should be designated as “in press” only if formally accepted for publication; otherwise “unpublished results” should be used.

Table of Contents Graphic. Authors should also submit a small structural diagram or other informative illustration for use in the Table of Contents (TOC) and abstract. This small graphic element, in conjunction with the title, should capture the reader’s attention and give a quick impression of the importance of the paper. For best presentation, this graphic should be no wider than 3.5 inches (9.0 cm) and no taller than 2 inches (5.1 cm), and it usually contains color.

Supporting Information

This information is provided to the reviewers during the peer-review process (for Review Only) and is available to readers of the published work (for Publication). Supporting Information must be submitted at the same time as the manuscript. See the list of Acceptable Software by File Designation and confirm that your Supporting Information is viewable.

If the manuscript is accompanied by any supporting information files for publication, these files will be made available free of charge to readers. A brief description of each file is required, and the paragraph and descriptions should be placed at the end of the manuscript before the list of references. The appropriate format is as follows:

Supporting Information. Brief descriptions in nonsentence format listing the contents of the files supplied as Supporting Information.

When including supporting information for review only, include copies of references that are unpublished or in-press. These files are available only to editors and reviewers.

Data Requirements

Abbrevations. Standard abbreviations should be used throughout the manuscript. Note that abbreviations are used in ACS journals without periods. The preferred forms for some of the more commonly used abbreviations are mp, bp, °C, K, kDa (for kilodalton), min, h, mL, μL, g, mg, μg, cm, mm, μm, nm, mol, mmol, μmol, nmol, ppm, HPLC, TLC, GC, NMR, LC-MS, and UV.

For lengthy technical names used more than five times in the manuscript, it is appropriate to employ abbreviations. Such nonstandard abbreviations should be collected and defined in a single Abbreviations paragraph at the end of the text. Excessive use of abbreviations makes a manuscript difficult to read; failure to collect the definitions of all abbreviations into a single paragraph is a disservice to the reader.

Safety. Authors must emphasize any unexpected, new, and/or significant hazards or risks associated with the reported work. Precautions for handling dangerous materials or for performing hazardous procedures must be stated or referenced. This information should be in the experimental details section of the full article or communication.

Characterization of New Compounds and Bioconjugates. ACS journals require a high standard of chemical characterization, to confirm the identity and purity of the compounds under study. Papers that explore conjugation conditions for multifunctional molecules, e.g., amino groups on proteins, should include analytical studies to identify the sequence positions of the residues affected. For medium-sized or larger peptides, evidence for homogeneity by separation methods of adequate resolving power and by amino acid analysis is normally required. For small organic molecules, the conventional practices of organic chemistry apply, including nuclear magnetic resonance data (for recommended practices see NMR guidelines available in the ACS Publishing Center here and elemental analyses and/or high resolution mass spectrometry of all new small molecules if practical. The numerical results for all elemental analyses should be included in Supporting Information.

Biological Data. Manuscripts generally will contain biological data such as images of cells or animal models, or other appropriate functional validations of the properties of new bioconjugates. Biological test methods must be referenced or described in sufficient detail to permit the experiments to be repeated by others. Statistical limits (statistical significance) are required for all biological data. Doses and concentrations should be expressed as molar quantities (e.g., mol/kg, nM) whenever possible.

Language and Editing Services

A well-written paper helps share your results most clearly. ACS Publications’ English Editing Service is designed to help scientists communicate their research effectively. Our subject-matter expert editors will edit your manuscript for grammar, spelling, and other language errors so your ideas are presented at their best.

Preparing Graphics

The quality of illustrations in ACS journals and partner journals depends on the quality of the original files provided by the authors. Figures are not modified or enhanced by journal production staff. All graphics must be prepared and submitted in digital format.

Graphics should be inserted into the main body whenever possible. Please see Appendix 2 for additional information.

Any graphic (figure chart, scheme, or equation) that has appeared in an earlier publication should include a credit line citing the original source. Authors are responsible for obtaining written permission to re-use this material.

Figure and Illustration Services

The impact of your research is not limited to what you can express with words. Tables and figures such as graphs, photographs, illustrations, diagrams, and other visuals can play a significant role in effectively communicating your findings. Our Figures service generates publication-ready figures that conform to your chosen journal’s specifications. This includes changes to file type, resolution, color space, font, scale, line weights, and layout (to improve readability and professional appearance).

Preparing For Submission

Manuscripts, graphics, supporting information, and required forms, as well as manuscript revisions, must all be submitted in digital format through ACS Paragon Plus, which requires an ACS ID to log in. Registering for an ACS ID is fast, free, and does not require an ACS membership. Please refer to Appendix 1 for additional information on preparing your submission

Prior Publication Policy

Bioconjugate Chemistry authors are allowed to deposit an initial draft of their manuscript in a preprint service such as ChemRxiv, arXiv, bioRxiv, or the applicable repository for their discipline prior to submission. Please note any use of a preprint server in the cover letter, and as appropriate, state how the manuscript has been adjusted/updated between deposition and submission. All other prior/redundant publication is forbidden.

Upon publication in Bioconjugate Chemistry, authors are requested to add a link from the preprint to the published paper via the Digital Object Identifier (DOI). For further details contact the Editorial Office.

Editorial Policies

Manuscripts are handled expeditiously, and full advantage is taken of Web technology in the submission and review of manuscripts.

The Review Process

Editors evaluate submitted manuscripts, and only those judged to fall within the scope of the journal and to be of potential interest to our readers are sent to two or more reviewers for evaluation. Reviewers can suggest that a paper be published, revised, or rejected. Reviewers will evaluate the originality, technical quality, clarity of presentation, and importance to the field. The editors evaluate the reviewers’ arguments in the context of the scope and aims of the journal and make the final decision on each manuscript.

Please note that editorial decisions are based on many factors. Reviewers’ concerns are considered very seriously. In cases when reviewers suggest differing decisions, additional information may be requested from the reviewers, other experts may be consulted, and/or the authors may be asked to clarify questionable sections. Reviewers may be asked to review subsequent versions of the manuscript, especially if new data have been added to the paper, to evaluate whether the authors have addressed the scientific concerns. In such cases, blind copies of all reviewer comments are normally sent to the reviewers. This practice allows the reviewers to obtain a clear understanding of the expectations of the editors. The editors will expedite any additional rounds of reviews to ensure timely publication.

Anonymity

The ACS strongly disapproves of any attempts by authors to determine the identity of reviewers or to confront potential reviewers. The editorial policy of this journal is to neither confirm nor deny any speculation about the identities of our reviewers. The journal will not release the identity of a reviewer to the authors or to other reviewers.

Providing Potential Reviewer Names

Please suggest 4-6 reviewers. Authors are encouraged to avoid suggesting reviewers from the authors’ institutions. Do not suggest reviewers who may have a real or perceived conflict of interest. Whenever possible, suggest academic email addresses rather than personal email addresses.

Manuscript Transfer

If your submission is declined for publication by this journal, the editors might deem your work to be better suited for another ACS Publications journal or partner journal and suggest that the authors consider transferring the submission. Manuscript Transfer simplifies and shortens the process of submitting to another ACS journal or partner journal, as all the coauthors, suggested reviewers, manuscript files, and responses to submission questions are copied by ACS Paragon Plus to the new draft submission. Authors are free to accept or decline the transfer offer.

Note that each journal is editorially independent. Transferring a manuscript is not a guarantee that the manuscript will be accepted, as the final publication decision will belong to the editor of the next journal.

PRODUCTION AND PUBLICATION

Proofs via ACS Direct Correct

Correction of the galley proofs is the responsibility of the Corresponding Author. The Corresponding Author of an accepted manuscript will receive e-mail notification and complete instructions when page proofs are available for review via ACS Direct Correct. Extensive or important changes on page proofs, including changes to the title or list of authors, are subject to review by the editor.

It is the responsibility of the Corresponding Author to ensure that all authors listed on the manuscript agree with the changes made on the proofs. Galley proofs should be returned within 48 hours in order to ensure timely publication of the manuscript.

Publication Date and Patent Dates

Accepted manuscripts will be published on the ACS Publications Web site as soon as page proofs are corrected and all author concerns are resolved. The first date on which the document is published on the Web is considered the publication date.

Publication of manuscripts on the Web may occur weeks in advance of the cover date of the issue of publication. Authors should take this into account when planning their patent and intellectual property activities related to a document and should ensure that all patent information is available at the time of first publication, whether ASAP or issue publication.

All articles published ahead of print receive a unique Digital Object Identifier (DOI) number, which is used to cite the manuscript before and after the paper appears in an issue. Additionally, any supplemental information submitted along with the manuscript will automatically be assigned a DOI and hosted on Figshare to promote open data discoverability and use of your research outputs.

ASAP Publication

Manuscripts will be published on the “ASAP Articles” page on the web as soon as page proofs are corrected and all author concerns are resolved. ASAP publication usually occurs within a few working days of receipt of page proof corrections, which can be several weeks in advance of the cover date of the issue.

Post-Publication Policies

The American Chemical Society follows guidance from the Committee on Publication Ethics (COPE) when considering any ethical concerns regarding a published article, Retractions, and Expressions of Concern.

Additions and Corrections

Additions and Corrections may be requested by the author(s) or initiated by the Editor to address important issues or correct errors and omissions of consequence that arise after publication of an article. All Additions and Corrections are subject to approval by the Editor, and should bring new and directly relevant information and corrections that fix scientific facts. Minor corrections and additions will not be published. Readers who detect errors of consequence in the work of others should contact the corresponding author of that work.

Additions and Corrections must be submitted as new manuscripts via ACS Paragon Plus by the Corresponding Author for publication in the “Addition/Correction” section of the Journal. The corresponding author should obtain approval from all coauthors prior to submitting or provide evidence that such approval has been solicited. The manuscript should include the original article title and author list, citation including DOI, and details of the correction.

Retractions

Articles may be retracted for scientific or ethical reasons and may be requested by the article author(s) or by the journal Editor(s), but are ultimately published at the discretion of the Editor. Articles that contain seriously flawed or erroneous data such that their findings and conclusions cannot be relied upon may be retracted in order to correct the scientific record. When an article is retracted, a notice of Retraction will be published containing information about the reason for the Retraction. The originally published article will remain online except in extraordinary circumstances (e.g. where deemed legally necessary, or if the availability of the published content poses public health risks).

Expressions of Concern

Expressions of Concern may be issued at the discretion of the Editor if:

there is inconclusive evidence of research or publication misconduct by the authors;

there is evidence that the findings are unreliable but the authors’ institution will not investigate the case;

an investigation into alleged misconduct related to the publication either has not been, or would not be, fair and impartial or conclusive;

an investigation is underway but a judgment will not be available for a considerable time.

Upon completion of any related investigation, and when a final determination is made about the outcome of the article, the Expression of Concern may be replaced with a Retraction notice or Correction.

Sharing Your Published Article

At ACS Publications, we know it is important for you to be able to share your peer reviewed, published work with colleagues in the global community of scientists. As sharing on sites known as scholarly collaboration networks (SCNs) is becoming increasingly prevalent in today’s scholarly research ecosystem, we would like to remind you of the many ways in which you, a valued ACS author, can share your published work.

Publishing open access makes it easy to share your work with friends, colleagues, and family members. In addition, ACS Publications makes it easy to share your newly published research with ACS Articles on Request (see below). Don’t forget to promote your research and related data on social media, at conferences, and through scholarly communication networks. Increase the impact of your research using the following resources: Altmetrics, Figshare, ACS Certified Deposit

E-Prints

When your article is published in an ACS journal or partner journal, corresponding authors are provided with a link that offers up to 50 free digital prints of the final published work. This link is valid for the first 12 months following online publication, and can be shared via email or an author’s website. After one year, the access restrictions to your article will be lifted, and you can share the Articles on Request URL on social media and other channels. To access all your Articles on Request links, log in to your ACS Publishing Center account and visit the “My Published Manuscripts” page.

Reprints

Article, journal, and commercial reprints are available to order.

Appendix 1: PREPARING FOR SUBMISSION

We’ve developed ACS’ publishing and editorial policies in consultation with the research communities that we serve, including authors and librarians. Browse our policies below to learn more.

Ethical Guidelines

ACS editors have provided Ethical Guidelines for persons engaged in the publication of chemical research—specifically, for editors, authors, and reviewers. Each journal also has a specific policy on prior publication.

Safety Considerations

Authors must emphasize any unexpected, new, and/or significant hazards or risks associated with the reported work. This information should be in the Experimental Section of a full article and included in the main text of a letter. Additional information on communicating safety information from the ACS Guide to Scholarly Communication is freely available here.

Conflict of Interest Disclosure

A statement describing any financial conflicts of interest or lack thereof is published in each ACS journal and partner journal article.

During the submission process, the Corresponding Author must provide a statement on behalf of all authors of the manuscript, describing all potential sources of bias, including affiliations, funding sources, and financial or management relationships, that may constitute conflicts of interest. If the manuscript is accepted, the statement will be published in the final article.

If the manuscript is accepted and no conflict of interest has been declared, the following statement will be published in the final article: “The authors declare no competing financial interest.”

Plagiarism

In publishing only original research, ACS is committed to deterring plagiarism, including self-plagiarism. ACS Publications uses CrossCheck's iThenticate software to screen submitted manuscripts for similarity to published material. Note that your manuscript may be screened during the submission process.

Further information about plagiarism can be found in Part B of the Ethical Guidelines to Publication of Chemical Research. See also the press release regarding ACS' participation in the CrossCheck initiative.

Author List and Coauthor Notification

Authors are required to obtain the consent of all their coauthors prior to submitting a manuscript. The submitting author accepts the responsibility of notifying all coauthors that the manuscript is being submitted.

If any change in authorship is necessary after a manuscript has been submitted, the Corresponding Author must e-mail a signed letter to the Editor-in-Chief confirming that all of the original coauthors have been notified and have agreed to the change. If the change involves the removal of a coauthor’s name, the Corresponding Author must, in addition, arrange for the coauthor involved to e-mail a separate signed letter to the Editor-in-Chief consenting to the change. No changes in the author list will be permitted after a manuscript has been accepted.

During manuscript submission, the submitting author must provide contact information (full name, email address, institutional affiliation, and mailing address) for all of the coauthors. Because all of the author names are automatically imported into the electronic Journal Publishing Agreement, the names must be entered into ACS Paragon Plus. (Note that coauthors are not required to register in ACS Paragon Plus.)

Patent Activities and Intellectual Property

Authors are responsible for ensuring that all patent activities and intellectual property issues are satisfactorily resolved prior to first publication (ASAP or in issue). Acceptance and publication will not be delayed for pending or unresolved issues of this nature.

Open Researcher and Contributor ID (ORCID)

Authors submitting manuscript revisions are required to provide their own personal, validated ORCID iD before completing the submission, if an ORCID iD is not already associated with their ACS Paragon Plus user profiles. This ID may be provided during original manuscript submission or when submitting the manuscript revision. All authors are strongly encouraged to register for an ORCID iD, a unique researcher identifier. The ORCID iD will be displayed in the published article for any author on a manuscript who has a validated ORCID iD associated with ACS when the manuscript is accepted.

ORCID iDs should not be typed into the manuscript. ACS publishes only those ORCID iDs that have been properly verified and linked before the manuscript is accepted. After your ORCID iD is linked, it will be displayed automatically in all subsequently accepted manuscripts for any/all ACS journals. We do not publish ORCID iDs provided during proof review or via other communications after a manuscript is accepted for publication.

With an ORCID iD, you can create a profile of your research activities to distinguish yourself from other researchers with similar names, and make it easier for your colleagues to find your publications. If you do not yet have an ORCID iD, or you wish to associate your existing ORCID iD with your ACS Paragon Plus account, you may do so by clicking on “Edit Your Profile” from your ACS Paragon Plus account homepage and following the ORCID-related links. Learn more at www.orcid.org.

Copyright and Permissions

To obtain forms and guidelines for copyright transfer, obtaining permissions from copyright owners, and to explore a Copyright Learning Module for chemists, click here.

Funder Reporting Requirement

Authors are required to report funding sources and grant/award numbers. Enter ALL sources of funding for ALL authors in BOTH the Funder Registry Tool in ACS Paragon Plus and in your manuscript to meet this requirement.

Open Access Compliance

ACS offers options by which authors can fulfill the requirements for open access and deposition into repositories for funded research. Visit our ACS Open Science site to see how to fulfill requirements for specific funders and to find out if you are eligible to publish under a Read + Publish agreement between ACS and your institution. You can also find out more about Open Access Compliance and ACS Open Science initiatives.

Appendix 2: Preparing Graphics

Resolution

Digital graphics pasted into manuscripts should have the following minimum resolutions:

Black and white line art, 1200 dpi

Grayscale art, 600 dpi

Color art, 300 dpi

Size

Graphics must fit a one- or two-column format. Single-column graphics can be sized up to 240 points wide (3.33 in.) and double-column graphics must be sized between 300 and 504 points (4.167 in. and 7 in.). The maximum depth for all graphics is 660 points (9.167 in.) including the caption (allow 12 pts. For each line of caption text). Lettering should be no smaller than 4.5 points in the final published format. The text should be legible when the graphic is viewed full-size. Helvetica or Arial fonts work well for lettering. Lines should be no thinner than 0.5 point.

Color

Color may be used to enhance the clarity of complex structures, figures, spectra, and schemes, etc., and color reproduction of graphics is provided at no cost to the author. Graphics intended to appear in black and white or grayscale should not be submitted in color.

Type of Graphics

Table of Contents (TOC)/Abstract Graphic

Consult the Guidelines for Table of Contents/Abstract Graphics for specifications.

Figures

A caption giving the figure number and a brief description must be included below each figure. The caption should be understandable without reference to the text. It is preferable to place any key to symbols used in the artwork itself, not in the caption. Ensure that any symbols and abbreviations used in the text agree with those in the artwork.

Charts

Charts (groups of structures that do not show reactions) may have a brief caption describing their contents.

Tables

Each table must have a brief (one phrase or sentence) title that describes the contents. The title should be understandable without reference to the text. Details should be put in footnotes, not in the title. Tables should be used when the data cannot be presented clearly in the narrative, when many numbers must be presented, or when more meaningful inter-relationships can be conveyed by the tabular format. Tables should supplement, not duplicate, information presented in the text and figures. Tables should be simple and concise.

Schemes

Each scheme (sequences of reactions) may have a brief caption describing its contents.

Chemical Structures

Chemical structures should be produced with the use of a drawing program such as ChemDraw.

Cover Art

The Editors will reach out to authors for proposed front cover art. Cover art should be colorful and interesting graphics with minimal text. It does not have to come from the manuscript. Images should be 8.438 inches wide x 7.375 inches high at 300 dpi. We are looking for high resolution, high-quality artwork. Acceptable formats are PSD, AI, TIF, PNG, EPS, JPG, PDF. We will also need a brief caption (20-30 words) describing the image. If your art is selected for front cover, ACS will send you information about how to request one complimentary 18” by 24” printed poster featuring your work.

Bioconjugate Chemistry also offers authors a great way to promote their work through Supplementary Covers. Submit your cover idea, artwork, and caption when submitting your manuscript revision in ACS Paragon Plus. If your article is accepted for publication, your suggestion may be selected for use on one of the journal’s supplementary covers.

Web Enhanced Objects (WEO)

The Web editions of ACS journals allow readers to view multimedia attachments such as animations and movies that complement understanding of the research being reported.

WEOs should be uploaded in ACS Paragon Plus with ‘Web Enhanced Object’ selected as the file designation. Consult the list of compatible WEO formats.


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭